Indicators
Indicators
Value
Direction
MACD(12,26,9)
0.416
Neutral
RSI(14)
34.733
Neutral
STOCH(KDJ)(9,3,3)
36.310
Buy
ATR(14)
1.998
Low Volatility
CCI(14)
-82.386
Neutral
Williams %R
71.429
Sell
TRIX(12,20)
-1.350
Sell
StochRSI(14)
56.273
Buy
Claritev Corp
CTEV25.910USD
+0.210+0.82%
Close 02/06, 16:00（ET）Quotes delayed by 15 min
427.76MMarket Cap
LossP/E TTM
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison
TradingKey Stock Score of Claritev Corp
Currency: USD Updated: 2026-02-06Key Insights
Claritev Corp's fundamentals are relatively weak, with an industry-leading ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 76 out of 156 in the Professional & Commercial Services industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 64.80.In the medium term, the stock price is expected to trend down.Despite a weak stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Claritev Corp's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
Very Low
Very High
Negative
Claritev Corp Highlights
StrengthsRisks
Claritev Corp, formerly MultiPlan Corporation, is a healthcare technology, data and insights company. The Company’s services include analytics-based services, data & decision science services, network-based services, payment and revenue integrity, end-to-end surprise billing service, and Claritev payments. The Company uses its analytics-based services to price surprise bills and leverages reimbursement data from millions of claims repriced through these services and accepted by providers to assist in negotiations and calculate offers for arbitration when necessary. It uses its payment integrity services on its network claims. The Company’s payment integrity offers advanced code editing, clinical negotiation, itemized bill review, coordination of benefits, subrogation, data mining, Medicare secondary payer validation, and end stage renal disease validation. It provides solutions for the commercial market, government healthcare plans, and property and casualty healthcare payors.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 930.62M.
Fairly Valued
The company’s latest PE is -1.24, at a medium 3-year percentile range.
Institutional Selling
The latest institutional holdings are 17.38M shares, decreasing 1.37% quarter-over-quarter.
Held by HACAX
Star Investor HACAX holds 182.00 shares of this stock.
Analyst Rating
Based on
5
analysts
Buy
Current Rating
64.800
Target Price
+152.14%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Financial Health
Currency: USD Updated: 2026-02-06The current financial score of Claritev Corp is 6.03, ranking 140 out of 156 in the Professional & Commercial Services industry. Its financial status is weak, and its operating efficiency is average. Its latest quarterly revenue reached 245.96M, representing a year-over-year increase of 6.71%, while its net profit experienced a year-over-year increase of 82.18%.
Score
Financials
3.38
Key Metrics
Cash and cash equivalents
Total assets
Total liabilities
Free cash flow
Relevant data have not been disclosed by the company yet.
Quality of Earnings
5.68
Operational Efficiency
7.10
Growth Potential
6.96
Shareholder Returns
7.03
Claritev Corp's Company Valuation
Currency: USD Updated: 2026-02-06The current valuation score of Claritev Corp is 7.75, ranking 62 out of 156 in the Professional & Commercial Services industry. Its current P/E ratio is -1.24, which is -89.72% below the recent high of -0.13 and -383.64% above the recent low of -5.99.
Score
Valuation Dimensions
P/E
P/B
P/S
P/CF
Industry Ranking 76/156
Relevant data have not been disclosed by the company yet.
Earnings Forecast
Currency: USD Updated: 2026-02-06The current earnings forecast score of Claritev Corp is 8.40, ranking 22 out of 156 in the Professional & Commercial Services industry. The average price target is 90.00, with a high of 95.00 and a low of 80.00.
Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Analyst Rating
Based on
5
analysts
Buy
Current Rating
64.800
Target Price
+152.14%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
78
Total
5
Median
8
Average
Company name
Ratings
Analysts
Claritev Corp
CTEV
5
Block Inc
XYZ
44
PayPal Holdings Inc
PYPL
44
Visa Inc
V
42
Fiserv Ord Shs
FISV
36
Fiserv Inc
FI
36
1
2
3
...
16
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Relevant data have not been disclosed by the company yet.
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Price Momentum
Currency: USD Updated: 2026-02-06The current price momentum score of Claritev Corp is 6.35, ranking 126 out of 156 in the Professional & Commercial Services industry. Currently, the stock price is trading between the resistance level at 31.49 and the support level at 21.99, making it suitable for range-bound swing trading.
Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Indicators
The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.
This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.
Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.
Moving Average
Indicators
Value
Direction
MA5
26.112
Sell
MA10
26.698
Sell
MA20
28.376
Sell
MA50
35.272
Sell
MA100
45.654
Sell
MA200
44.980
Sell
Institutional Confidence
Currency: USD Updated: 2026-02-06The current institutional shareholding score of Claritev Corp is 10.00, ranking 1 out of 156 in the Professional & Commercial Services industry. The latest institutional shareholding proportion is 96.77%, representing a quarter-over-quarter decrease of 0.52%. The largest institutional shareholder is The Vanguard, holding a total of 581.91K shares, representing 3.52% of shares outstanding, with 35.90% increase in holdings.
Score
Institutional Shareholding
Relevant data have not been disclosed by the company yet.
Shareholder Activity
Name
Shares Held
Chg %
Hellman & Friedman LLC
Ares Management LLC
Public Investment Fund
Arini Capital Management Limited
GIC Private Limited
Klein (Michael Stuart)
BlackRock Institutional Trust Company, N.A.
Cohen Private Ventures, LLC
Beach Point Capital Management, LP
1
2
Risk Assessment
Currency: USD Updated: 2026-02-06The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Professional & Commercial Services domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of Claritev Corp is 2.60, ranking 126 out of 156 in the Professional & Commercial Services industry. The company's beta value is 0.53. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets. with an industry-leading ESG disclosure.
Score
Beta vs S&P 500 index
0.53
VaR
+8.89%
240-Day Maximum Drawdown
+65.28%
240-Day Volatility
+103.33%
Return
Best Daily Return
60 days
+11.77%
120 days
+12.78%
5 years
+94.90%
Worst Daily Return
60 days
-24.60%
120 days
-24.60%
5 years
-32.84%
Sharpe Ratio
60 days
-2.51
120 days
-1.68
5 years
+0.01
Risk Assessment
Maximum Drawdown
240 days
+65.28%
3 years
+94.21%
5 years
+98.63%
Return-to-Drawdown Ratio
240 days
-0.17
3 years
-0.13
5 years
-0.19
Skewness
240 days
+0.19
3 years
+3.20
5 years
+2.98
Volatility
Realised Volatility
240 days
+103.33%
5 years
+103.28%
Standardised True Range
240 days
+11.99%
5 years
+23.40%
Downside Risk-Adjusted Return
120 days
-204.64%
240 days
-204.64%
Maximum Daily Upside Volatility
60 days
+67.11%
Maximum Daily Downside Volatility
60 days
+82.38%
Liquidity
Average Turnover Rate
60 days
+0.81%
120 days
+0.66%
5 years
--
Turnover Deviation
20 days
-87.22%
60 days
-88.05%
120 days
-90.28%
Peer Comparison
Professional & Commercial Services
Claritev Corp
CTEV
6.88 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Brady Corp
BRC
8.77 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
McGrath RentCorp
MGRC
8.68 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Ennis Inc
EBF
8.64 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
RB Global Inc
RBA
8.48 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Brinks Co
BCO
8.47 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
View more
